Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01801826 · ClinicalTrials.gov registry record
A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device
A clinical trial, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- 61
- Enrollment target
NCT01801826 is a clinical trial that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 61 participants.
The verdict
NCT01801826 has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
myoscience Inc. (Redwood City, CA) has developed a device for a novel, minimally invasive facial rejuvenation procedure designed to soften hyperdynamic facial lines. The myoscience Cryo-Touch IV device uses well-established principles of cryobiology to cause localized reduction in muscle activity resulting in a reversible reduction in facial animation and the appearance of facial lines. The device operates on well-established cryobiology principles; that localized exposure to controlled low temperature conditions can alter tissue function. The therapy treats targeted motor nerves with low temperatures via a cold probe in the form of an assembly of small diameter needles, creating a highly localized treatment zone around the probe. The thermal algorithm is designed to produce a reversible loss of nerve conduction resulting in a temporary decrease in muscle contractility. Prior studies of Cryo-Touch, Cryo-Touch II and Cryo-Touch III have provided strong evidence of effectiveness and safety for applications in this indication. The goal of the study described herein is to show the safety and effectiveness of this approach using the Cryo-Touch IV device.
Interventions
- DEVICE Treatment with CryoTouch IV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01801826
The ClinicalTrials.gov registry entry for NCT01801826 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment with CryoTouch IV is the first listed.
NCT01801826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01801826 about?
NCT01801826 is a clinical study titled "A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device". myoscience Inc. (Redwood City, CA) has developed a device for a novel, minimally invasive facial rejuvenation procedure designed to soften hyperdynamic facial lines. The myoscience Cryo-Touch IV device uses well-established principles of cryobiology to cause localized reduction in muscle activity re...
What is the current status of trial NCT01801826?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2013-01. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01801826?
The interventions under investigation include: Treatment with CryoTouch IV (DEVICE).
Who is sponsoring clinical trial NCT01801826?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.